| Title | Content | Date | Document Link |
|---|---|---|---|
| List of Authorized Clinical Trial Applications May 2025 | List of Authorized Clinical Trial Applications May 2025 | May 21, 2025 | |
| Medicine Formulary 3rd edition 2025 | Medicine Formulary 3rd edition 2025 | May 15, 2025 | |
| 1061_የህክምና_ጋዝ_ማምረቻ_ተቋማት_ቁጥጥር_መመሪያ_ቁጥር_1061_2017 | 1061_የህክምና_ጋዝ_ማምረቻ_ተቋማት_ቁጥጥር_መመሪያ_ቁጥር_1061_2017 | May 15, 2025 | |
| April 2025 newsletter | April 2025 newsletter | April 22, 2025 | |
| Medicine Manufacturing Establishments Control Directive 1054/2025 | 1054-2017-የመድኃኒት ማምረቻ ተቋማት ቁጥጥር መመሪያ ቁጥር 1054-2017 | April 11, 2025 | |
| Medicine Good Manufacturing Practice Inspection Procedure 1055/2025 | 1055-2017-የመድኃኒት የመልካም አመራረት ስርዓት ቁጥጥር አሰራር መመሪያ ቁጥር 1055-2017 | April 11, 2025 | 1055-2017-የመድኃኒት የመልካም አመራረት ስርዓት ቁጥጥር አሰራር መመሪያ ቁጥር 1055-2017 |
| Pharmaceutical Products Barcoding Guideline | Pharmaceutical Products Barcoding Guideline | April 9, 2025 | |
| Master data Guideline 2nd Edition 2024 | Master data Guideline 2nd Edition 2024 | April 9, 2025 | |
| Global Trade Item Number GTIN Allocation Guideline | Global Trade Item Number GTIN Allocation Guideline | April 9, 2025 | |
| Global Location Number GLN Allocation Guideline | Global Location Number GLN Allocation Guideline | April 9, 2025 | |
| Guideline for Temporary Marketing Authorization of Medicinal Gasses | Guideline for Temporary Marketing Authorization of Medicinal Gasses | April 1, 2025 | Guideline for Temporary Marketing Authorization of Medicinal Gasses |
| FQSCD ACCREDITATION CERTIFICATE 3 | FQSCD ACCREDITATION CERTIFICATE 3 | March 24, 2025 | |
| FQSCD ACCREDITATION CERTIFICATE 2 | FQSCD ACCREDITATION CERTIFICATE 2 | March 24, 2025 | |
| FQSCD ACCREDITATION CERTIFICATE 1 | FQSCD ACCREDITATION CERTIFICATE 1 | March 24, 2025 | |
| Trends in Antimicrobial Consumption in Ethiopia A Surveillance Report 2020-2022 | Trends in Antimicrobial Consumption in Ethiopia A Surveillance Report 2020-2022 | March 18, 2025 | Trends in Antimicrobial Consumption in Ethiopia A Surveillance Report 2020-2022 |
| Budget distribution for 2017 EC | Budget distribution for 2017 EC | February 10, 2025 | |
| Guideline for Registration of Low risk Medicines | Guideline for Registration of Low risk Medicines | February 9, 2025 | |
| Guideline for Registration of Low risk Medicines | Guideline for Registration of Low risk Medicines | February 8, 2025 | |
| 043/2025 Bioequivalence Center and Bioanalytical Laboratory Control Directive | 1043-2017 የባዮኤክቫለንስ ጥናት ማዕከል እና የባዮአናሊቲካል ላብራቶሪ ቁጥጥር መመሪያ ቁጥር 1043-2017 | February 7, 2025 | 1043-2017 የባዮኤክቫለንስ ጥናት ማዕከል እና የባዮአናሊቲካል ላብራቶሪ ቁጥጥር መመሪያ ቁጥር 1043-2017 |
| 1041 – የአስተዳደራዊ እርምጃ አወሳሰድ፣ ቅሬታ አቀራረብና አወሳሰን ስነ-ስርዐት መመሪያ ቁጥር 1041-2017 | 1041 – የአስተዳደራዊ እርምጃ አወሳሰድ፣ ቅሬታ አቀራረብና አወሳሰን ስነ-ስርዐት መመሪያ ቁጥር 1041-2017 | February 7, 2025 | 1041 – የአስተዳደራዊ እርምጃ አወሳሰድ፣ ቅሬታ አቀራረብና አወሳሰን ስነ-ስርዐት መመሪያ ቁጥር 1041-2017 |
| Ethiopian Essential Medicines List Oct- 2024 | Ethiopian Essential Medicines List Oct- 2024 | February 7, 2025 | |
| SRA GMP Waiver Application form | SRA GMP Waiver Application form | February 5, 2025 | |
| GCP Inspection Guideline | GCP Inspection Guideline | February 4, 2025 | |
| List of Authorized Clinical Trial Applications January 2025 | List_of_Authorized_Clinical_Trial_Applications_January_2025 | January 27, 2025 | |
| 23.01.2025 Guidelines on procedures and data requirements for changes to approved biotherapeutic products | 23.01.2025 Guidelines on procedures and data requirements for changes to approved biotherapeutic products | January 23, 2025 |